Additionally, SMAD3 rescue assays showed that reintroducing SMAD3 could partially reverse the effects of NAT10 knockdown on several critical processes involved in HCC progression, including cell proliferation, invasion, EMT disruption, apoptosis, and anoikis in vitro. The gene discussed is SMAD3; the disease is hepatocellular carcinoma.